The Trump administration is accelerating efforts to integrate artificial intelligence into U.S. medical care, deploying AI agents for diagnosis and treatment. The Department of Health and Human Services leads the initiative, facing concerns from officials who argue change is moving too quickly with inadequate safety evidence. Vinod Khosla, a billionaire Silicon Valley venture capitalist, has been particularly influential in these discussions, advocating for AI to replace human doctors. Dr. Mehmet Oz, head of Medicare and Medicaid, and Chris Klomp, awaiting confirmation as deputy health secretary, support the technology. Khosla predicts AI will largely replace physicians, stating "It's over for doctors, human doctors." However, the American Medical Association warns AI models for independent patient care "are not ready for prime time." Grace Davis Jamison, a health department spokeswoman, defends the approach as "responsible, evidence-based," aiming to "Make America Healthy Again." Federal officials are developing a new Medicare payment category to reimburse AI software supporting diagnosis. The F.D.A. has approved over 1,500 AI medical devices for discrete tasks, though newer chatbot models lack specific regulations.

\n\nKey concerns include the outsized influence of tech investors on federal health policy and the readiness of AI to assume physician roles. While AI aids administrative tasks, experts question evidence showing AI superiority over doctors, noting reliance on simulations. The administration pushes forward despite calls to regulate AI development pace, seeking to balance innovation with patient safety in the national healthcare system.